Kristen Harrington-Smith - Jun 9, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Kristen Harrington-Smith
Stock symbol
EFTR
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 06:46 PM
Previous filing
Feb 17, 2022
Next filing
Nov 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +13.3K $0.00 13.3K Jun 9, 2022 Common Stock 13.3K $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.